Copyright
©The Author(s) 2025.
World J Gastroenterol. Jan 7, 2025; 31(1): 98561
Published online Jan 7, 2025. doi: 10.3748/wjg.v31.i1.98561
Published online Jan 7, 2025. doi: 10.3748/wjg.v31.i1.98561
Figure 7 Kangfuxin solution inhibited upregulation of TGF-β1/Smads signaling in primary esophageal fibroblast.
A-C: RT-PCR to detect gene transcription level of Transforming growth factor β1 (TGF-β1), Smad2, and Smad3; D: The western boltting determined the protein expression of TGF-β1, Smad2/3, and p-Smad2/3; E-I: Quantitation of proteins expression in D; compared to the TGF-β1 group, KFX significantly downregulated endogenous p-Smad2/3 expression; J: Representative images of immunofluorescence staining of p-Smad2 and p-Smad3, magnification, 400 ×. Data are presented as mean ± SE. hP < 0.001 vs the negative control group, iP < 0.001 vs the TGF-β1 group, jP < 0.01 vs the TGF-β1 group. NC: Negative control group; KFX: Kangfuxin solution; TGF-β1: Transforming growth factor β1; WB: Western blotting.
- Citation: Zhou X, Ma D, He YX, Jin J, Wang HL, Wang YF, Yang F, Liu JQ, Chen J, Li Z. Kangfuxin solution alleviates esophageal stenosis after endoscopic submucosal dissection: A natural ingredient strategy. World J Gastroenterol 2025; 31(1): 98561
- URL: https://www.wjgnet.com/1007-9327/full/v31/i1/98561.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i1.98561